Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Ko AC"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ko Achterberg
Publikováno v:
MAB, Vol 84, Iss 4, Pp 200-208 (2010)
De vraag die in dit artikel centraal staat, is of het vakgebied Bestuurlijke informatieverzorging (BIV), ook wel benoemd als Accounting Information Systems (AIS), voldoet aan de elementaire kenmerken van wat een vakgebied tot een wetenschappelijke di
Externí odkaz:
https://doaj.org/article/60e8d4acecca4184af79a1f2b3bbd4c4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Liu KZ; Life Sciences Division, Medical Devices Research Centre, National Research Council of Canada, 435 Ellice Avenue, Winnipeg, MB, R3B 1Y6, Canada., Tian G; Life Sciences Division, Medical Devices Research Centre, National Research Council of Canada, 435 Ellice Avenue, Winnipeg, MB, R3B 1Y6, Canada., Ko AC; Life Sciences Division, Medical Devices Research Centre, National Research Council of Canada, 435 Ellice Avenue, Winnipeg, MB, R3B 1Y6, Canada., Geissler M; Life Sciences Division, Medical Devices Research Centre, National Research Council of Canada, 75 de Mortagne Boulevard, Boucherville, QC, J4B 6Y4, Canada. matthias.geissler@cnrc-nrc.gc.ca., Malic L; Life Sciences Division, Medical Devices Research Centre, National Research Council of Canada, 75 de Mortagne Boulevard, Boucherville, QC, J4B 6Y4, Canada. matthias.geissler@cnrc-nrc.gc.ca., Moon BU; Life Sciences Division, Medical Devices Research Centre, National Research Council of Canada, 75 de Mortagne Boulevard, Boucherville, QC, J4B 6Y4, Canada. matthias.geissler@cnrc-nrc.gc.ca., Clime L; Life Sciences Division, Medical Devices Research Centre, National Research Council of Canada, 75 de Mortagne Boulevard, Boucherville, QC, J4B 6Y4, Canada. matthias.geissler@cnrc-nrc.gc.ca., Veres T; Life Sciences Division, Medical Devices Research Centre, National Research Council of Canada, 75 de Mortagne Boulevard, Boucherville, QC, J4B 6Y4, Canada. matthias.geissler@cnrc-nrc.gc.ca.
Publikováno v:
The Analyst [Analyst] 2024 Oct 23. Date of Electronic Publication: 2024 Oct 23.
Autor:
Palomino-Padilla S; Universidad Peruana Cayetano Heredia, Lima, Peru., Caceres-Cardenas G; Universidad Peruana Cayetano Heredia, Lima, Peru., Calderon R; Universidad Peruana Cayetano Heredia, Lima, Peru., Ko AC; Medical Devices Research Centre, National Research Council Canada (NRC), Boucherville, ON, Canada., Garnett L; National Microbiology Laboratory, Public Health Agency of Canada (PHAC), Winnipeg, ON, Canada., Doan K; National Laboratory for HIV Immunology, Public Health Agency of Canada, Winnipeg, ON, Canada., Chong P; National Microbiology Laboratory, Public Health Agency of Canada (PHAC), Winnipeg, ON, Canada., Lino H; Universidad Peruana Cayetano Heredia, Lima, Peru., Caceres T; Universidad Peruana Cayetano Heredia, Lima, Peru., Veres T; National Research Council Canada (NRC), Ottawa, ON, Canada., Dos Santos CC; University of Toronto, Toronto, ON, Canada., Nielsen B; National Research Council Canada (NRC), Ottawa, ON, Canada., Ugarte-Gil C; Universidad Peruana Cayetano Heredia, Lima, Peru.
Publikováno v:
Frontiers in public health [Front Public Health] 2024 May 09; Vol. 12, pp. 1344295. Date of Electronic Publication: 2024 May 09 (Print Publication: 2024).
Autor:
Koseki T; Department of Pharmacotherapeutics and Informatics, School of Medicine, Fujita Health University, Toyoake 470-1192, Japan., Teramachi M; Center for Clinical Trial and Research Support, School of Medicine, Fujita Health University, Toyoake 470-1192, Japan., Koga M; KM Pharmaceutical Consulting, Washington, DC 20006, USA., Ko MSH; Elixirgen Therapeutics, Inc., Baltimore, MD 21205, USA., Amano T; Elixirgen Therapeutics, Inc., Baltimore, MD 21205, USA., Yu H; Elixirgen Therapeutics, Inc., Baltimore, MD 21205, USA., Amano M; Elixirgen Therapeutics, Inc., Baltimore, MD 21205, USA., Leyder E; Elixirgen Therapeutics, Inc., Baltimore, MD 21205, USA., Badiola M; Elixirgen Therapeutics, Inc., Baltimore, MD 21205, USA., Ray P; Elixirgen Therapeutics, Inc., Baltimore, MD 21205, USA., Kim J; Elixirgen Therapeutics, Inc., Baltimore, MD 21205, USA., Ko AC; Elixirgen Therapeutics, Inc., Baltimore, MD 21205, USA., Achour A; Laboratory of Molecular Biology and Immunology, National Institute on Aging, National Institutes of Health, Baltimore, MD 20892, USA., Weng NP; Laboratory of Molecular Biology and Immunology, National Institute on Aging, National Institutes of Health, Baltimore, MD 20892, USA., Imai T; Department of Medical Statistics, Graduate School of Medicine, Osaka Metropolitan University, Osaka 545-8585, Japan., Yoshida H; Department of Medical Statistics, Graduate School of Medicine, Osaka Metropolitan University, Osaka 545-8585, Japan., Taniuchi S; Department of Medical Statistics, Graduate School of Medicine, Osaka Metropolitan University, Osaka 545-8585, Japan., Shintani A; Department of Medical Statistics, Graduate School of Medicine, Osaka Metropolitan University, Osaka 545-8585, Japan., Fujigaki H; Department of Advanced Diagnostic System Development, Graduate School of Health Sciences, Fujita Health University, Toyoake 470-1192, Japan., Kondo M; Center for Clinical Trial and Research Support, School of Medicine, Fujita Health University, Toyoake 470-1192, Japan.; Department of Respiratory Medicine, School of Medicine, Fujita Health University, Toyoake 470-1192, Japan., Doi Y; Departments of Microbiology and Infectious Diseases, School of Medicine, Fujita Health University, Toyoake 470-1192, Japan.; Center for Infectious Disease Research, Fujita Health University, Toyoake 470-1192, Japan.; Division of Infectious Diseases, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15213, USA.
Publikováno v:
Vaccines [Vaccines (Basel)] 2023 Nov 27; Vol. 11 (12). Date of Electronic Publication: 2023 Nov 27.
Autor:
Tran C; Carver College of Medicine, Iowa City, IA., Choi D; Carver College of Medicine, Iowa City, IA., Wang K; Department of Biostatistics, College of Public Health, Iowa City, IA., Carter KD; Department of Ophthalmology and Visual Sciences, University of Iowa, Iowa City, IA., Ko AC; Department of Ophthalmology and Visual Sciences, University of Iowa, Iowa City, IA; Wolfe Eye Clinic, West Des Moines, IA., Shriver EM; Department of Ophthalmology and Visual Sciences, University of Iowa, Iowa City, IA. Electronic address: erin-shriver@uiowa.edu.
Publikováno v:
Canadian journal of ophthalmology. Journal canadien d'ophtalmologie [Can J Ophthalmol] 2023 Jun; Vol. 58 (3), pp. 229-234. Date of Electronic Publication: 2021 Dec 16.
Autor:
Amano T; Elixirgen Therapeutics, Inc., Baltimore, MD, USA., Yu H; Elixirgen Therapeutics, Inc., Baltimore, MD, USA., Amano M; Elixirgen Therapeutics, Inc., Baltimore, MD, USA., Leyder E; Elixirgen Therapeutics, Inc., Baltimore, MD, USA., Badiola M; Elixirgen Therapeutics, Inc., Baltimore, MD, USA., Ray P; Elixirgen Therapeutics, Inc., Baltimore, MD, USA., Kim J; Elixirgen Therapeutics, Inc., Baltimore, MD, USA., Ko AC; Elixirgen Therapeutics, Inc., Baltimore, MD, USA., Achour A; Laboratory of Molecular Biology and Immunology, National Institute on Aging, NIH, Baltimore, MD, USA., Weng NP; Laboratory of Molecular Biology and Immunology, National Institute on Aging, NIH, Baltimore, MD, USA., Kochba E; NanoPass Technologies Ltd., Ness Ziona, Israel., Levin Y; NanoPass Technologies Ltd., Ness Ziona, Israel., Ko MSH; Elixirgen Therapeutics, Inc., Baltimore, MD, USA.
Publikováno v:
IScience [iScience] 2023 Mar 05; Vol. 26 (4), pp. 106335. Date of Electronic Publication: 2023 Mar 05 (Print Publication: 2023).